| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/1999 | CA2244619A1 Crystalline progestagens |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0895999A1 C-4" substituted macrolide antibiotics |
| 02/10/1999 | EP0895994A2 Sulphonamide-substituted Pyranopyridines, process for their production and their use as a drug or diagnostics as well as medicaments containing them |
| 02/10/1999 | EP0895989A1 1-[4-(Substituted alkoxy)benzyl] naphthalene compounds having estrogen inhibitory activity |
| 02/10/1999 | EP0895988A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/10/1999 | EP0895783A2 Pharmaceutical composition comprising ifosfamide and carnitine |
| 02/10/1999 | EP0895782A2 Pharmaceutical compositions of Cilansetron stabilized against racemisation |
| 02/10/1999 | EP0895781A2 Use of benzofurans, benzothiophenes or indoles for the manufacture of a medicament for the treatment of conditions associated with an excess of tachykinins |
| 02/10/1999 | EP0895780A1 Extended release tablets particularly containing pseudoephedrine hydrochloride |
| 02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 02/10/1999 | EP0895534A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| 02/10/1999 | EP0895479A1 Diabetes treatment |
| 02/10/1999 | EP0895478A1 Component b as cicatrizant |
| 02/10/1999 | EP0895475A1 Vitronectin receptor antagonists |
| 02/10/1999 | EP0895473A1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 02/10/1999 | EP0895470A1 Agent and method for permanently shaping the hair, based on n-branched-chain alkyl-substituted mercapto acetamides and process for their preparation |
| 02/10/1999 | EP0766699B1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
| 02/10/1999 | EP0719138B1 Iontophoretic delivery of an antimigraine drug |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | EP0693120B1 Tumoricide t lymphocytes |
| 02/10/1999 | EP0659174B1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 02/10/1999 | CN1207811A Method of diagnosing and treating epithelioma |
| 02/10/1999 | CN1207775A Conditionally replicating viral vectors and their use |
| 02/10/1999 | CN1207771A Methods and compositions for diagnosis and treatment of cancer |
| 02/10/1999 | CN1207769A Tissue-specific and target RNA-specific ribozymes |
| 02/10/1999 | CN1207741A Synthetic metal-substituted bacteriochlorophyll derivs. and use thereof |
| 02/10/1999 | CN1207740A Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 02/10/1999 | CN1207734A Metalloproteinase inhibitors, pharmaceutical compositions contg. them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 02/10/1999 | CN1207733A Novel piperazinylalkylthiophrimidine derivs., pharmaceutical compositions contg. same and process for preparation of such compounds |
| 02/10/1999 | CN1207731A 3-pyrazolecarboxamide derivs. having cannabinoid receptor affinity |
| 02/10/1999 | CN1207730A Quinoline derivs. |
| 02/10/1999 | CN1207729A Quinoline-4-carboxamide derivs., their preparation and their use as neurokinin 3 (NK-3)- and neurokinin 2 (NK-2) receptor antagonists |
| 02/10/1999 | CN1207728A Salt of quinoline derivs. as NK3 antagonists |
| 02/10/1999 | CN1207727A Substd. aryl or heteroarylamides having retinoid-like biological activity |
| 02/10/1999 | CN1207726A New mfg. process |
| 02/10/1999 | CN1207724A Amino alcohol derivs., method of producing said derivs., and medicaments contg. them |
| 02/10/1999 | CN1207687A Pharmaceutical compositions with vitamin D analogues |
| 02/10/1999 | CN1207685A Novel medical use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 02/10/1999 | CN1207684A Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/10/1999 | CN1207681A Sustained-release microgranules contg. diltiazem as active principle |
| 02/10/1999 | CN1207680A Use of certain isoquinolinesulfonyl compounds for treatment of glaucoma and ocular ischemia |
| 02/10/1999 | CN1207679A Use of cholinesterase inhibitors in treatment of xerostomia |
| 02/10/1999 | CN1207678A Excitatory amino acid receptor antagonists |
| 02/10/1999 | CN1207677A Pharmaceutical compositions comprising flurbiprofen |
| 02/10/1999 | CN1207676A Use of inhibitors of cellular Na+/H+ exchanger (NHE) for preparation of drug for respiratory stimulation |
| 02/10/1999 | CN1207675A Sublingual and buccal administration of selegiline |
| 02/10/1999 | CN1207673A Endoparasiticidal agents |
| 02/10/1999 | CN1207672A Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 02/10/1999 | CN1207671A PGE-1 contg. lyophilized liposomes for use in treatment of erectile dysfunction |
| 02/10/1999 | CN1207670A Cosmetic composition and method for reducing ageing processes of skin |
| 02/10/1999 | CN1207669A Dual component tooth whitening dentifrice |
| 02/10/1999 | CN1207668A Cosmetic compositions for hair or skin based on sulfone copolyesters with polyorganosiloxane units |
| 02/10/1999 | CN1207392A Viformyl cumarins compound, process for preparing same and pharmaceutical composition contg. same |
| 02/10/1999 | CN1207391A Sulfonamide-substituted compounds, processes for their preparation, their use and medicament comprising them |
| 02/10/1999 | CN1207384A Amino compounds of 6,7,8,9-tetrahydro-cyclopenta[a]naphthalene and of 2,3-dihydro-cyclopenta[e]indene |
| 02/10/1999 | CN1207318A Ointment for treating burn and scald |
| 02/10/1999 | CN1207293A Use of polyethenoxy sorbitan monooleate as sensitizer for thermotherapy of tumor, and preparing method thereof |
| 02/10/1999 | CN1207292A Stable anti-racemic medicinal preparation of cilancetlone |
| 02/10/1999 | CN1207291A Use of substituted 2,4-imidazolidinedione compounds as analgesics |
| 02/10/1999 | CN1042033C Process for preparation of azithromycin dihydrochloride |
| 02/10/1999 | CN1042032C Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions contg. them |
| 02/10/1999 | CN1042031C Quaternary nitrogen-contg. phosphonate compounds, pharmaceutical compositions and use thereof |
| 02/10/1999 | CN1042030C Method for preparing substituted dibenzofurans |
| 02/10/1999 | CN1042026C 25 carboxylic deriv. of vitamin D series, its preparing method, middle products in production of same and medicine contg. same and pharmaceutical use of same in treatment |
| 02/10/1999 | CN1041992C Preparation process of common cold resistant panacea tablet |
| 02/09/1999 | US5869734 Chemical intermediate to the production of deoxyspergualin and salts |
| 02/09/1999 | US5869714 Salts with aminoalcohols exhibiting antithrombotic and thrombolytic activities; oral administration for cardiovascular disorders |
| 02/09/1999 | US5869711 Ceramide compounds, process for their preparation and use |
| 02/09/1999 | US5869685 Serotonin reuptake inhibitors |
| 02/09/1999 | US5869680 Reacting a oxazolidine derivative with protected hydroxy-taxol; decyclization and amination |
| 02/09/1999 | US5869670 7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof |
| 02/09/1999 | US5869669 Reacting with an oxidizing agent in the presence of a weak acid |
| 02/09/1999 | US5869666 4',6'-cyclopropane-fused carboxylic nucleoside analogs in which the oxygen in the ribose ring is substituted for carbon; antimetabolites; locking dna in solution to examine dna-protein, dna-rna and dna-dna interactions |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869659 Microbiocides |
| 02/09/1999 | US5869633 Thrombin receptor homolog polynucleotide |
| 02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
| 02/09/1999 | US5869539 Source of nitric oxide; administering to treat hypertension, or where increased blood flow is desirable; no negative side effects due to drug metabolites |
| 02/09/1999 | US5869538 Method for enhancing transport of gases to tissues |
| 02/09/1999 | US5869537 Macrophage lipid chemoattractant |
| 02/09/1999 | US5869536 Administering 2-(4-methylaminobutoxy)diphenylmethane |
| 02/09/1999 | US5869535 Method and composition for selectively inhibiting melanoma |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869533 Non-irritating capsaicin formulations and applicators therefor |
| 02/09/1999 | US5869531 No undesireable salidiuretic properties; treating ischemia induced disorders |
| 02/09/1999 | US5869530 Dietetic phospholipid compositions and use thereof as a dietary supplement |
| 02/09/1999 | US5869529 Topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus |
| 02/09/1999 | US5869528 Administering l-carnitine or alkanoyl l-carnitine |
| 02/09/1999 | US5869527 6-(N-carboxymethylamino)caproate, salts thereof and methods of use therefor |
| 02/09/1999 | US5869526 δ-(S-methylisothioureido)-L-norvaline therapeutic for cerebrovascular diseases having nitric oxide synthase inhibiting factor |
| 02/09/1999 | US5869525 Ascorbic acid drugs for intracerebral administration |
| 02/09/1999 | US5869524 Indene inhibitors of COX-2 |
| 02/09/1999 | US5869523 Protecting forskolin, deacetylating, treating with beta-halopropionyl halide, treating with alkali, acetylating, reacting with amine, deprotecting |
| 02/09/1999 | US5869522 Solvent extraction; plant extracts; trimerization of 2,3-deoxy-1,4-naphthoquinone |
| 02/09/1999 | US5869521 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |